GlassScriptPhysician profile
Stephen T Dudick
NPI 1508890526
$5,895.07
in general payments reported to CMS, 2019-2025
14 companies · $587 in 2025
The $587 reported for 2025 was more than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
See the full distribution for Surgery of the Hand (Plastic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $3,157 · 2021: $211 · 2022: $236 · 2023: $398 · 2024: $904 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,888.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,532.19 | 2019-2022 | |
| Abbvie INC. | $518.33 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Musculoskeletal Transplant Foundation INC. | $330.64 | 2024-2025 | |
| Tela Bio, INC. | $248.28 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Convatec INC. | $216.72 | 2024-2025 | |
| Polynovo North America LLC | $171.84 | 2023 | |
| Acera Surgical, INC. | $160.84 | 2024 | Restrata Wound Matrix |
| Derma Sciences, INC. | $133.30 | 2019 | |
| Davol INC. | $130.56 | 2024 | Phasix Mesh |
| Baudax Bio INC. | $124.77 | 2022 | |
| Zimmer Biomet Holdings, INC. | $116.32 | 2019 | |
| Mentor Worldwide LLC | $100.00 | 2019 | |
| Kerecis Limited | $92.53 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Gilead Sciences, INC. | $18.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Dudick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.